EBAA wishes to support innovative companies which advance the science of eye banking and corneal transplantation and will consider investing in products and services that serve eye banks, corneal surgeons, or the patients they care for. Read EBAA’s investment policy for details about the opportunities EBAA is considering. Current EBAA investments include OcuCell and Kerify Vision. Announcements can be found on our Press Releases page.
Please use the form below to share your investment opportunity with EBAA. Proposals are reviewed on a quarterly basis and may lead to presentations to the Board of Directors or its appointed subcommittee on investments.
EBAA also provides grants to support primary research into the causes and cures of corneal disease and dysfunction.